AI
THC icon

Atria Investments’s Tenet Healthcare THC Stock Holding History

Atria Investments’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$698K Sell
3,729
-8,135
-69% -$1.5M 0.01% 1322
2026
Q1 		$2.24M Sell
11,864
-1,222
-9% -$257K 0.03% 660
2025
Q4 		$2.6M Buy
13,086
+7,982
+156% +$1.61M 0.03% 614
2025
Q3 		$1.04M Sell
5,104
-816
-14% -$145K 0.01% 1041
2025
Q2 		$1.04M Buy
5,920
+594
+11% +$89.4K 0.01% 1012
2025
Q1 		$716K Buy
5,326
+1,939
+57% +$255K 0.01% 1159
2024
Q4 		$428K Sell
3,387
-484
-13% -$72K 0.01% 1406
2024
Q3 		$643K Buy
3,871
+935
+32% +$141K 0.01% 1205
2024
Q2 		$391K Buy
+2,936
New +$353K 0.01% 1434
2015
Q3 		– Sell
-3,562
Closed -$206K – 408
2015
Q2 		$206K Buy
+3,562
New +$182K 0.02% 377
2015
Q1 		– Sell
-3,982
Closed -$202K – 441
2014
Q4 		$202K Sell
3,982
-646
-14% -$33.8K 0.02% 403
2014
Q3 		$275K Sell
4,628
-381
-8% -$21.3K 0.03% 383
2014
Q2 		$235K Sell
5,009
-1,549
-24% -$70K 0.02% 379
2014
Q1 		$281K Sell
6,558
-4,228
-39% -$187K 0.03% 373
2013
Q4 		$454K Buy
10,786
+592
+6% +$25.8K 0.05% 308
2013
Q3 		$420K Sell
10,194
-650
-6% -$27.2K 0.04% 307
2013
Q2 		$500K Buy
+10,844
New +$486K 0.06% 181

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Atria Investments's THC Position: Q2 2026 in Review

Atria Investments reduced its Tenet Healthcare (THC) stake by 69% in Q2 2026, selling an estimated $1.5M and leaving 3,729 shares worth $698K. The position accounts for 0.01% of the portfolio, ranked #1322.

Atria Investments first reported a position in THC in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.6M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Atria Investments held 3,729 shares of Tenet Healthcare worth $698K as of Q2 2026.
  • Atria Investments sold 8,135 Tenet Healthcare shares in Q2 2026, an estimated $1.5M.
  • Tenet Healthcare made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1322 holding.
  • Atria Investments first reported a position in Tenet Healthcare in Q2 2013 and has held it in 17 quarters since.
  • Atria Investments's Tenet Healthcare position peaked at $2.6M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.